Views & Analysis Healthcare’s hype cycle: which technologies will stay the co... Where should pharma invest to remain at the forefront of healthcare?
Articles Digital health round-up: Philips' IoT, bioprinting and more A round-up of this week's top digital healthcare news. Marco Ricci reports.
News Agios shares slide as it abandons sickle cell candidate Agios Pharma has said it will halt clinical development of tebapivat, a PK activator that had reached phase 2 testing in sickle cell disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
